To characterize the role of SLFN5 in TGFβ1-induced EMT of ovarian cancer cells, we first determined the expression level of SLFN5 in SKOV3 and OVCAR3 cells when treated with 10 ng/ml TGF-β1 for 48 h. Here, SLFN5 is linked to ovarian cancer.